These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6683542)

  • 1. In vitro--in vivo correlation, a time scaling problem? Basic techniques for testing equivalence.
    Brockmeier D; Voegele D; von Hattingberg HM
    Arzneimittelforschung; 1983; 33(4):598-601. PubMed ID: 6683542
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro--in vivo correlation, a time scaling problem? Basic considerations on in vitro dissolution testing.
    Brockmeier D; von Hattingberg HM
    Arzneimittelforschung; 1982; 32(3):248-51. PubMed ID: 6896279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic availability and therapeutic equivalence.
    Arnold JD; Sicé J
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):546-9. PubMed ID: 977793
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug biodisponibility and generic equivalence (author's transl)].
    Jaminet F
    J Pharm Belg; 1977; 32(4):325-46. PubMed ID: 599404
    [No Abstract]   [Full Text] [Related]  

  • 5. USP standards for dissolution and bioavailability.
    Grady LT
    Am J Hosp Pharm; 1982 Sep; 39(9):1546-8. PubMed ID: 7137198
    [No Abstract]   [Full Text] [Related]  

  • 6. Investigation on different levels of in vitro-in vivo correlation: gemfibrozil immediate release capsule.
    Rouini MR; Ardakani YH; Mirfazaelian A; Hakemi L; Baluchestani M
    Biopharm Drug Dispos; 2008 Sep; 29(6):349-55. PubMed ID: 18615873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates.
    Khan MK; Khan MF; Khan H; Mustafa G
    Pak J Pharm Sci; 2009 Jul; 22(3):329-34. PubMed ID: 19553184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
    Chen ML
    Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BEQUIV interactive microcomputer program for testing equivalence in two-group comparative bioavailability trials.
    Durisová M; Trnovec T
    Methods Find Exp Clin Pharmacol; 1988 Feb; 10(2):129-33. PubMed ID: 3361979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory aspects of drug dissolution from a European perspective.
    Graffner C
    Eur J Pharm Sci; 2006 Nov; 29(3-4):288-93. PubMed ID: 16950606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversy. II: Bioequivalence as an indicator of therapeutic equivalence: modeling the theoretic influence of bioinequivalence on single-dose drug effect.
    Olson SC; Eldon MA; Toothaker RD; Ferry JJ; Colburn WA
    J Clin Pharmacol; 1987; 27(5):342-5. PubMed ID: 3693579
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bioequivalence of solid drug preparation].
    Ejima A
    Eisei Shikenjo Hokoku; 1982; (100):1-20. PubMed ID: 6897833
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of operating parameters on the in vitro drug availability test from suppositories.
    Realdon N; Ragazzi E
    Pharmazie; 2000 Dec; 55(12):954-5. PubMed ID: 11189877
    [No Abstract]   [Full Text] [Related]  

  • 14. Brand X.
    Krawford KS
    Mod Vet Pract; 1978 Sep; 59(9):649. PubMed ID: 714006
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biological equivalence study of chlortetracycline preparations used in veterinary medicine].
    Kovalev VF; Volkov IB; LIstkov GI
    Antibiotiki; 1981 Jun; 26(6):445-7. PubMed ID: 7271257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic systems: 1. Basic concepts and characteristics].
    Davila D
    Lijec Vjesn; 1986 Apr; 108(4):159-62. PubMed ID: 3713429
    [No Abstract]   [Full Text] [Related]  

  • 17. A new statistical procedure for testing equivalence in two-group comparative bioavailability trials.
    Hauck WW; Anderson S
    J Pharmacokinet Biopharm; 1984 Feb; 12(1):83-91. PubMed ID: 6747820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential clinical significance of differences in bioavailability.
    Hosp Formul; 1976 Sep; 11(9):484, 487-8. PubMed ID: 10316482
    [No Abstract]   [Full Text] [Related]  

  • 19. [Testing of methods for the determination of in vitro drug liberation in suppositories].
    Pflegel P; Sivako N; Elze H
    Pharmazie; 1986 Feb; 41(2):152-3. PubMed ID: 3725858
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
    Kortejärvi H; Urtti A; Yliperttula M
    Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.